Free Trial

Evogene (EVGN) Competitors

Evogene logo
$1.25 -0.03 (-1.97%)
Closing price 03:58 PM Eastern
Extended Trading
$1.25 +0.00 (+0.32%)
As of 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

EVGN vs. CARM, SNES, TOMZ, BSLK, GURE, CNEY, NITO, ENFY, TANH, and GAMCW

Should you be buying Evogene stock or one of its competitors? The main competitors of Evogene include Carisma Therapeutics (CARM), Senestech (SNES), TOMI Environmental Solutions (TOMZ), Bolt Projects (BSLK), Gulf Resources (GURE), CN Energy Group. (CNEY), N2OFF (NITO), Enlightify (ENFY), Tantech (TANH), and Golden Arrow Merger (GAMCW).

Evogene vs. Its Competitors

Evogene (NASDAQ:EVGN) and Carisma Therapeutics (NASDAQ:CARM) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, valuation, media sentiment, analyst recommendations, institutional ownership and risk.

Evogene currently has a consensus target price of $3.50, indicating a potential upside of 181.12%. Carisma Therapeutics has a consensus target price of $1.93, indicating a potential upside of 5,173.97%. Given Carisma Therapeutics' higher possible upside, analysts clearly believe Carisma Therapeutics is more favorable than Evogene.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Evogene
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.67
Carisma Therapeutics
1 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.50

Evogene has higher earnings, but lower revenue than Carisma Therapeutics. Evogene is trading at a lower price-to-earnings ratio than Carisma Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Evogene$8.51M0.79-$16.49M-$2.25-0.55
Carisma Therapeutics$10.77M0.14-$60.48M-$1.56-0.02

10.4% of Evogene shares are owned by institutional investors. Comparatively, 44.3% of Carisma Therapeutics shares are owned by institutional investors. 7.4% of Evogene shares are owned by company insiders. Comparatively, 6.9% of Carisma Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Evogene has a net margin of -211.61% compared to Carisma Therapeutics' net margin of -254.28%. Carisma Therapeutics' return on equity of 0.00% beat Evogene's return on equity.

Company Net Margins Return on Equity Return on Assets
Evogene-211.61% -109.96% -38.47%
Carisma Therapeutics -254.28%N/A -192.17%

Evogene has a beta of 1.56, meaning that its share price is 56% more volatile than the S&P 500. Comparatively, Carisma Therapeutics has a beta of 2.06, meaning that its share price is 106% more volatile than the S&P 500.

In the previous week, Carisma Therapeutics had 1 more articles in the media than Evogene. MarketBeat recorded 1 mentions for Carisma Therapeutics and 0 mentions for Evogene. Evogene's average media sentiment score of 0.00 equaled Carisma Therapeutics'average media sentiment score.

Company Overall Sentiment
Evogene Neutral
Carisma Therapeutics Neutral

Summary

Carisma Therapeutics beats Evogene on 9 of the 15 factors compared between the two stocks.

Get Evogene News Delivered to You Automatically

Sign up to receive the latest news and ratings for EVGN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EVGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EVGN vs. The Competition

MetricEvogeneMED IndustryMedical SectorNASDAQ Exchange
Market Cap$6.69M$3.42B$6.17B$10.67B
Dividend YieldN/A2.24%5.72%4.86%
P/E Ratio-0.5523.2129.5928.52
Price / Sales0.79477.49578.90129.07
Price / CashN/A45.5937.1261.42
Price / Book0.4510.3412.046.52
Net Income-$16.49M-$52.53M$3.32B$276.75M
7 Day Performance-2.73%-0.29%-0.17%0.21%
1 Month Performance6.23%10.83%5.75%1.68%
1 Year Performance-50.40%14.10%65.69%32.79%

Evogene Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EVGN
Evogene
2.2885 of 5 stars
$1.25
-2.0%
$3.50
+181.1%
-54.5%$6.69M$8.51M-0.55140Gap Up
CARM
Carisma Therapeutics
2.5506 of 5 stars
$0.04
-19.5%
$1.93
+5,131.0%
-96.4%$1.54M$19.63M-0.0220
SNES
Senestech
1.9195 of 5 stars
$3.98
-3.2%
$10.00
+151.3%
+32.0%$19.54M$1.86M-0.7330
TOMZ
TOMI Environmental Solutions
2.0186 of 5 stars
$0.96
-2.6%
$3.50
+266.5%
+6.2%$19.18M$7.74M-4.1520Upcoming Earnings
Short Interest ↑
BSLK
Bolt Projects
0.9856 of 5 stars
$3.56
-1.9%
N/A-72.2%$13.29M$1.37M-1.3812Short Interest ↓
GURE
Gulf Resources
0.8283 of 5 stars
$0.51
-1.6%
N/A-27.9%$6.75M$7.66M-0.20420News Coverage
Positive News
Stock Split
Short Interest ↓
CNEY
CN Energy Group.
1.1091 of 5 stars
$2.12
+1.2%
N/A-87.9%$6.38M$50.96M0.00160News Coverage
Positive News
NITO
N2OFF
0.5218 of 5 stars
$4.41
-0.2%
N/A-60.9%$4.19M$210K0.002
ENFY
Enlightify
1.1907 of 5 stars
$0.10
-72.8%
N/AN/A$1.58M$95.85M-0.08424Short Interest ↓
Gap Down
High Trading Volume
TANH
Tantech
0.3912 of 5 stars
$1.73
+0.9%
N/A-82.3%$155K$42.94M0.0070Gap Down
GAMCW
Golden Arrow Merger
N/A$0.04
-1.6%
N/AN/A$0.00N/A0.0012Gap Up

Related Companies and Tools


This page (NASDAQ:EVGN) was last updated on 10/23/2025 by MarketBeat.com Staff
From Our Partners